<qa>  What is the first-line THERAPY in TREATING PATIENTS WITHDOCETAXEL WITH EITHER CETUXIMAB OR BORTEZOMIB AS FIRST-LINE THERAPY IN TREATING PATIENTS WITH STAGE III OR STAGE IV NON-SMALL CELL LUNG CANCER: 